Concentric Capital Strategies’s Eli Lilly LLY Stock Holding History

Concentric Capital Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Buy	2,007 +1,159	+137%	+$1.18M	0.16%	106
2025 Q4	$911K	Buy	848 +33	+4%	+$31.6K	0.04%	208
2025 Q3	$622K	Sell	815 -25	-3%	-$18.6K	0.03%	236
2025 Q2	$655K	Buy	+840	New	+$653K	0.03%	240
2025 Q1	–	Sell	-5,058	Closed	-$3.9M	–	239
2024 Q4	$3.9M	Sell	5,058 -15,052	-75%	-$12.5M	0.18%	113
2024 Q3	$17.8M	Buy	20,110 +1,991	+11%	+$1.79M	0.73%	21
2024 Q2	$16.4M	Buy	18,119 +12,673	+233%	+$10.1M	0.82%	18
2024 Q1	$4.24M	Buy	+5,446	New	+$3.88M	0.24%	103
2023 Q4	–	Sell	-947	Closed	-$509K	–	280
2023 Q3	$509K	Buy	+947	New	+$488K	0.05%	161

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Concentric Capital Strategies's LLY Position: Q1 2026 in Review

Concentric Capital Strategies increased its Eli Lilly (LLY) stake by 137% in Q1 2026, buying an estimated $1.18M and bringing the position to 2,007 shares worth $1.85M. The position accounts for 0.16% of the portfolio, ranked #106.

Concentric Capital Strategies first reported a position in LLY in Q3 2023 and has held it in 9 quarters since. The position peaked at $17.8M in Q3 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Concentric Capital Strategies held 2,007 shares of Eli Lilly worth $1.85M as of Q1 2026.
Concentric Capital Strategies bought 1,159 Eli Lilly shares in Q1 2026, an estimated $1.18M.
Eli Lilly made up 0.16% of Concentric Capital Strategies's portfolio in Q1 2026, its #106 holding.
Concentric Capital Strategies first reported a position in Eli Lilly in Q3 2023 and has held it in 9 quarters since.
Concentric Capital Strategies's Eli Lilly position peaked at $17.8M in Q3 2024.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Concentric Capital Strategies's 13F filing for Q1 2026, filed 15 May 2026.